• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Precision oncology and molecular therapies for hepatocellular carcinoma.

作者信息

Chen Liming, Xu Youcai, Li Gu

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Surgery, People's Hospital of Jingning She Autonomous County, Lishui, China.

出版信息

Hepatobiliary Surg Nutr. 2022 Dec;11(6):882-885. doi: 10.21037/hbsn-22-458.

DOI:10.21037/hbsn-22-458
PMID:36523923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9745622/
Abstract
摘要

相似文献

1
Precision oncology and molecular therapies for hepatocellular carcinoma.肝细胞癌的精准肿瘤学与分子疗法
Hepatobiliary Surg Nutr. 2022 Dec;11(6):882-885. doi: 10.21037/hbsn-22-458.
2
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma.基于免疫肿瘤学的新型疗法及其在肝细胞癌中的前景
Cancers (Basel). 2021 Jan 11;13(2):238. doi: 10.3390/cancers13020238.
3
Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.循环肿瘤 DNA 在肝细胞癌精准医学中的前景与挑战。
Clin Exp Med. 2020 Aug;20(3):329-337. doi: 10.1007/s10238-020-00620-9. Epub 2020 Apr 1.
4
Molecular targeted drugs, comprehensive classification and preclinical models for the implementation of precision immune oncology in hepatocellular carcinoma.分子靶向药物，综合分类和临床前模型，以实现肝癌精准免疫肿瘤学。
Int J Clin Oncol. 2022 Jul;27(7):1101-1109. doi: 10.1007/s10147-022-02174-0. Epub 2022 May 28.
5
Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine.肝细胞癌：精准医学时代的病理学作用。
Clin Liver Dis. 2020 Nov;24(4):591-610. doi: 10.1016/j.cld.2020.07.010. Epub 2020 Sep 3.
6
Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.迈向精准肿瘤学之路：回顾靶向治疗研究和工具，以帮助确定分子病变的“可操作性”和患者管理支持。
Mol Cancer Ther. 2017 Dec;16(12):2645-2655. doi: 10.1158/1535-7163.MCT-17-0597.
7
Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma.精准医学：肝细胞癌的诊断和治疗策略更新。
Curr Med Chem. 2018;25(17):1999-2008. doi: 10.2174/0929867325666180117101532.
8
The quest for precision oncology with immune checkpoint inhibitors for hepatocellular carcinoma.探索用于肝细胞癌的免疫检查点抑制剂的精准肿瘤学。
J Hepatol. 2022 Feb;76(2):262-264. doi: 10.1016/j.jhep.2021.11.021. Epub 2021 Nov 26.
9
Precision oncology in liver cancer.肝癌的精准肿瘤学
Ann Transl Med. 2018 Jul;6(14):285. doi: 10.21037/atm.2018.06.14.
10
[Hepatocellular carcinoma].[肝细胞癌]
Pathologe. 2020 Sep;41(5):478-487. doi: 10.1007/s00292-020-00801-z.

引用本文的文献

1
Microwave ablation in solitary hepatocellular carcinoma within 3-5 cm requiring consideration.需要考虑对直径3至5厘米的孤立性肝细胞癌进行微波消融治疗。
Hepatobiliary Surg Nutr. 2023 Aug 1;12(4):622-624. doi: 10.21037/hbsn-23-332. Epub 2023 Jul 14.

本文引用的文献

1
From conventional two-stage hepatectomy to ALPPS: Fifteen years of experience in a hepatobiliary surgery unit.从传统两阶段肝切除术到联合肝脏离断和门静脉结扎的分阶段肝切除术：一家肝胆外科单位的十五年经验
Hepatobiliary Pancreat Dis Int. 2021 Dec;20(6):542-550. doi: 10.1016/j.hbpd.2021.08.001. Epub 2021 Aug 14.
2
Postoperative adjuvant transcatheter arterial chemoembolization improves the prognosis of patients with huge hepatocellular carcinoma.术后辅助性经动脉化疗栓塞可改善巨大肝细胞癌患者的预后。
Hepatobiliary Pancreat Dis Int. 2021 Jun;20(3):232-239. doi: 10.1016/j.hbpd.2020.12.018. Epub 2021 Jan 5.
3
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).肝细胞癌诊疗指南（2019年版）
Liver Cancer. 2020 Dec;9(6):682-720. doi: 10.1159/000509424. Epub 2020 Nov 11.
4
Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis.小肝切除术：聚焦模糊的图景：无肝硬化患者 4471 例开放性切除术结果分析。
Ann Surg. 2019 Nov;270(5):842-851. doi: 10.1097/SLA.0000000000003493.
5
The evolving landscape of precision medicine in primary liver cancer.原发性肝癌精准医学的发展态势
Hepat Oncol. 2019 Jun 4;6(2):HEP12. doi: 10.2217/hep-2019-0004.
6
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
7
Hepatocellular carcinoma.肝细胞癌。
Lancet. 2018 Mar 31;391(10127):1301-1314. doi: 10.1016/S0140-6736(18)30010-2. Epub 2018 Jan 5.
8
How much liver needs to be transected in ALPPS? A translational study investigating the concept of less invasiveness.在联合肝脏分割和门静脉结扎的分阶段肝切除术（ALPPS）中需要切除多少肝脏？一项研究微创概念的转化研究。
Surgery. 2017 Feb;161(2):453-464. doi: 10.1016/j.surg.2016.08.004. Epub 2016 Nov 1.
9
Combination therapeutics in complex diseases.复杂疾病中的联合疗法。
J Cell Mol Med. 2016 Dec;20(12):2231-2240. doi: 10.1111/jcmm.12930. Epub 2016 Sep 7.
10
Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique.通过最小化第一阶段影响来反转ALPPS模式：迷你ALPPS技术。
Langenbecks Arch Surg. 2016 Jun;401(4):557-63. doi: 10.1007/s00423-016-1424-1. Epub 2016 Apr 15.